The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
2-Cyclopropyl-1-{4-[(2-{[6-(3-methyl-1,2,4-oxadiazol-5-yl)-1H-benzimidazol-2-yl]amino}pyridin-4-yl)methyl]piperazin-1-yl}ethan-1-one ID: ALA4483062
PubChem CID: 129245681
Max Phase: Preclinical
Molecular Formula: C25H28N8O2
Molecular Weight: 472.55
Molecule Type: Unknown
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: Cc1noc(-c2ccc3nc(Nc4cc(CN5CCN(C(=O)CC6CC6)CC5)ccn4)[nH]c3c2)n1
Standard InChI: InChI=1S/C25H28N8O2/c1-16-27-24(35-31-16)19-4-5-20-21(14-19)29-25(28-20)30-22-12-18(6-7-26-22)15-32-8-10-33(11-9-32)23(34)13-17-2-3-17/h4-7,12,14,17H,2-3,8-11,13,15H2,1H3,(H2,26,28,29,30)
Standard InChI Key: PEGMEQCMRMUMBG-UHFFFAOYSA-N
Molfile:
RDKit 2D
35 40 0 0 0 0 0 0 0 0999 V2000
33.7428 -2.2287 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.7417 -3.0523 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
34.4538 -3.4654 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
35.1676 -3.0519 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
35.1648 -2.2251 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
34.4520 -1.8198 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.0309 -1.8202 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
32.3191 -2.2290 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.5689 -1.8924 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
32.2344 -3.0414 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
31.4311 -3.2117 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.0230 -2.5001 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.2040 -2.5009 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.7922 -3.2124 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.2095 -3.9246 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.0270 -3.9204 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
35.8751 -1.8138 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
36.5884 -2.2197 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
36.5889 -3.0428 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
37.2941 -3.4528 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
38.0068 -3.0409 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
38.0057 -2.2186 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
37.2919 -1.8082 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.8024 -4.6420 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.9860 -4.7314 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
28.8199 -5.5357 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.5338 -5.9450 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
30.1425 -5.3911 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
28.0709 -5.8758 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
38.7187 -3.4536 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
38.7187 -4.2749 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
39.4305 -3.0409 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
39.4305 -2.2196 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
39.8424 -1.5112 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
39.0211 -1.5112 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 4 2 0
4 5 1 0
5 6 2 0
6 1 1 0
1 7 1 0
7 8 1 0
8 9 2 0
9 12 1 0
11 10 1 0
10 8 1 0
11 12 2 0
12 13 1 0
13 14 2 0
14 15 1 0
15 16 2 0
16 11 1 0
5 17 1 0
17 18 1 0
18 19 1 0
18 23 1 0
19 20 1 0
20 21 1 0
21 22 1 0
22 23 1 0
24 25 2 0
25 26 1 0
26 27 2 0
27 28 1 0
28 24 1 0
15 24 1 0
26 29 1 0
21 30 1 0
30 31 2 0
30 32 1 0
32 33 1 0
34 33 1 0
35 34 1 0
33 35 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 472.55Molecular Weight (Monoisotopic): 472.2335AlogP: 3.50#Rotatable Bonds: 7Polar Surface Area: 116.07Molecular Species: NEUTRALHBA: 8HBD: 2#RO5 Violations: ┄HBA (Lipinski): 10HBD (Lipinski): 2#RO5 Violations (Lipinski): ┄CX Acidic pKa: 11.14CX Basic pKa: 6.16CX LogP: 3.04CX LogD: 3.01Aromatic Rings: 4Heavy Atoms: 35QED Weighted: 0.42Np Likeness Score: -1.68
References 1. Lefranc J, Schulze VK, Hillig RC, Briem H, Prinz F, Mengel A, Heinrich T, Balint J, Rengachari S, Irlbacher H, Stöckigt D, Bömer U, Bader B, Gradl SN, Nising CF, von Nussbaum F, Mumberg D, Panne D, Wengner AM.. (2020) Discovery of BAY-985, a Highly Selective TBK1/IKKε Inhibitor., 63 (2): [PMID:31859507 ] [10.1021/acs.jmedchem.9b01460 ]